Role of Nanoparticles in Pharmacotherapy of Cancer Therapy
Despite several dozen medications, millions of people are dying every year due to cancer. Additionally, the survival patients suffer from various serious side effects due to the use of available anticancerdrugs. The development of nanoparticle based drugs seems to be effective providing low side effects and targeted action on cancer cells. Nanoparticles are particles between 1 and 100 nanometers in size. Nanoparticles have unique biological properties given their small size and large surface area-to-volume ratio, which allows them to bind, absorb, and carry compounds such as small molecule drugs, DNA, RNA, proteins, and probes with high efficiency. Their tunable size, shape, and surface characteristics also enable them to have high stability, high carrier capacity, greater ability to incorporate both hydrophilic and hydrophobic substances, and compatibility with different administration routes, thereby making them highly attractive in many aspects of oncology.